Diabetes Drugs Hijacked for Cosmetic Weight Loss

A concerning trend has emerged in Hyderabad where popular diabetes and weight-loss medications, including Ozempic, Wegovy, and Mounjaro, are being increasingly used for cosmetic weight loss rather than their intended medical purposes. Doctors report that individuals are obtaining these injectable GLP-1 drugs, which mimic natural hormones to regulate blood sugar and reduce appetite, often without a doctor's prescription. This misuse is frequently driven by social media trends and peer influence, with people seeking quick weight reduction before social events.

Health experts express particular concern about the upcoming market entry of cheaper generic versions of these drugs later this month. While lower prices could benefit patients genuinely needing treatment for diabetes and obesity, they are also expected to fuel further misuse by those seeking aesthetic improvements. Unsupervised use can lead to serious side effects such as nausea, gastric issues, and diarrhea, and potentially more severe complications like pulmonary aspiration if pre-surgery protocols are ignored.

Specialists emphasize that these medications require careful dose adjustment and monitoring by healthcare professionals. Beyond weight loss, drugs like Ozempic and Mounjaro aid in controlling blood sugar by increasing insulin secretion, making them beneficial for patients with co-existing diabetes and obesity. However, without proper medical supervision, balanced nutrition, and exercise, unsupervised use can result in muscle loss and other adverse health outcomes. Stricter regulations and enhanced public awareness are deemed essential to mitigate these risks.